Hey Investors,
Our Best Buys for June are here. 🎯
Each month, we look for great companies trading at attractive valuations and highlight three stocks that currently stand out to us.
Since December 2024, we’ve shared 54 Best Buys with our paid members.
So far, they've generated an impressive average return of 23.4%, with multiple positions already up triple digits 🔥
🚀 AMD: picked at $97.35, now +457%
🚀 ASML: picked at $662.63, now +161%
🚀 First Solar: picked at $126.43, now +152%
🚀 Alphabet: picked at $168.95, now +112%
Our selection combines valuation and fundamentals, but quality always comes first. As Warren Buffett famously said:
“It’s better to buy a wonderful company at a fair price than a fair company at a wonderful price.”
Learn more about how we score stocks on fundamentals in our Fundamental Scoring Framework article.
To keep our process sharp and ideas fresh, we don’t pick the same Best Buy two months in a row.
Now let’s dive into our Top 3 Best Buys for June ✨👇
Disclaimer:
The information and opinions provided in this article are for informational and educational purposes only and should not be considered as investment advice. Please consult the general disclaimer for more details.
#3: Intuitive Surgical (NASDAQ: ISRG)
This is the second time we’re adding Intuitive Surgical to our Best Buys list. The first time was in September 2025, when shares traded at $473. Today, the stock trades at $407, down 14% since our first pick, 28% this year, and 33% below its all-time high.
What makes this decline interesting to us is that Intuitive Surgical is still one of the highest-quality businesses in the market. More procedures are being performed using its systems, more da Vinci systems are being installed, and recurring revenue continues to grow.
The business is performing better than ever, making this an attractive opportunity for long-term investors 🎯
What Happened?
Intuitive Surgical is the clear leader in robotic surgery. Over the past two decades, the company has built a dominant position with its da Vinci systems, which are now used in thousands of hospitals worldwide.
Thanks to that leadership and consistent growth, investors have historically been willing to pay a premium valuation for the stock. Over the past 10 years, shares traded at an average P/E ratio of 68.8.
This year, the stock has come under pressure. Much of that can be explained by expectations for slower growth. Management expects procedure growth of 13.5% to 15.5% in 2026, compared to 18% growth in 2025. Competition is also increasing as companies like Medtronic, Johnson & Johnson, and several Chinese players continue to invest heavily in robotic surgery.
The company’s Q1 results were still very strong:
📊 Revenue grew 23%
🏥 Procedure volumes increased 17%
🤖 431 new da Vinci systems were installed
🌍 Installed base reached 11,395 systems
📈 Management raised its 2026 outlook
The stock may be under pressure, but the latest report showed that the business is still performing at a very high level.
Source: Intuitive Surgical Q1 2026 Investor Presentation
Why Intuitive Surgical Looks Attractive Now
Intuitive Surgical scores 78🟢 in our Fundamental Scoring Framework. That places the company in our Quality category and close to reaching High Quality status.
As we mentioned earlier, Intuitive Surgical has almost always traded at a premium valuation. Over the past 10 years, the stock traded at an average P/E ratio of 68.8.
Today, the stock trades at a P/E ratio below 50 and a forward P/E of 39.1. That’s about 43% below its historical average.
Free cash flow tells a similar story. Intuitive Surgical trades at a P/FCF ratio of 51.9, about 23% below its 10-year average.
Growth expectations also look healthy. Analysts expect both revenue and EPS to grow by around 14% per year over the next three years.
You’re buying a high-quality company with a dominant position in robotic surgery, a huge moat, and a long runway for growth. The key difference today is that you’re no longer paying the same premium valuation investors were willing to pay for most of the past decade.
The Future Investors (Vincent & Stefan) currently hold a position in Intuitive Surgical.
Fundamental Score: 78 🟢 → Quality
Current Stock Price: $407.29
The next two? One Quality 🟢 and one High Quality 🔵 company, both trading at extremely attractive valuations today:
👑 One is a global platform with exceptional cash flow growth.
🚀 The other is a market leader with exceptional margins and strong growth.
Ready to discover our #1 and #2 Best Buys?
Get instant access as a paid member 🔓✨
🔥 Upgrade Now and Save 30%
Get direct access to our other 2 Best Buys for June, all previous Best Buys, our Portfolios & Transactions, all Deep Dives, all Stock Battles — and 400+ premium articles.
✅ Already trusted by 4,700+ investors.